Tag: &amp

Trump Media & Technology Group sends letter to Nasdaq regarding 'naked' short selling

 stock analyst  04/19/2024  0 Comments on Trump Media & Technology Group sends letter to Nasdaq regarding 'naked' short selling

Trump Media & Technology Group (DJT) sent a letter to Nasdaq\’s CEO on Thursday warning of \”potential market manipulation\” of the company\’s stock via the \”naked\” short selling of shares.

Netflix raised to Buy at Needham & Company on revenue upside

 stock analyst  04/19/2024  0 Comments on Netflix raised to Buy at Needham & Company on revenue upside

On Friday, Netflix (NASDAQ:NFLX) received an upgrade to \’Buy\’ from \’Hold\’ by Needham, with the firm setting a new price target of $700 for the streaming giant\’s stock. The upgrade follows Netflix\’s first-quarter earnings release, which showcased a revenue of $9.4 billion, marking a 15% year-over-year increase and surpassing estimates by 1%. The company\’s GAAP earnings per share (EPS) also rose significantly by 83% year-over-year to $5.28, exceeding estimates by 18%.

Needham & Company reiterates Buy rating on Amazon, raises estimates

 stock analyst  04/18/2024  0 Comments on Needham & Company reiterates Buy rating on Amazon, raises estimates

On Thursday, Needham & Company reaffirmed its buy rating on Amazon (NASDAQ:AMZN) and maintained its price target on the stock at $205. The firm has increased its profit estimates for the e-commerce giant for fiscal year 2024 (FY24), citing a shareholder letter from CEO Andy Jassy, which indicated a focus on cost-cutting measures in Amazon\’s inbound fulfillment and inventory placement.

Earnings call: Johnson & Johnson posts solid Q1 growth, eyes M&A strategy

 stock analyst  04/17/2024  0 Comments on Earnings call: Johnson & Johnson posts solid Q1 growth, eyes M&A strategy

Johnson & Johnson (JNJ), a global healthcare giant, reported a 3.9% increase in worldwide sales, hitting $21.4 billion for the first quarter of 2024. The U.S. market saw a 7.8% increase, although international sales slightly declined by 0.3%. Excluding the COVID-19 vaccine impact, operational sales growth was 7.6% worldwide.

Johnson & Johnson posts mixed results, narrows full-year guidance

 stock analyst  04/16/2024  0 Comments on Johnson & Johnson posts mixed results, narrows full-year guidance

Johnson & Johnson (NYSE:JNJ) reported mixed financial results for the first quarter of 2024, with adjusted earnings per share (EPS) slightly surpassing analyst expectations, while revenue fell marginally short of estimates. The healthcare giant posted an adjusted EPS of $2.71, which was $0.07 higher than the consensus estimate of $2.64. However, quarterly revenue was a hair\’s breadth away from consensus, coming in at $21.38 billion against the expected $21.4 billion.